New York State Common Retirement Fund Has $19.13 Million Stock Holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

New York State Common Retirement Fund lessened its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 2.6% during the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 237,050 shares of the company's stock after selling 6,400 shares during the quarter. New York State Common Retirement Fund owned about 0.05% of GE HealthCare Technologies worth $19,132,000 at the end of the most recent quarter.

Several other large investors have also made changes to their positions in GEHC. Susquehanna Fundamental Investments LLC bought a new stake in GE HealthCare Technologies in the fourth quarter valued at about $20,891,000. Breakwater Capital Group bought a new stake in GE HealthCare Technologies in the first quarter valued at about $210,000. Flagship Harbor Advisors LLC increased its holdings in GE HealthCare Technologies by 17.4% in the first quarter. Flagship Harbor Advisors LLC now owns 3,443 shares of the company's stock valued at $278,000 after purchasing an additional 511 shares during the last quarter. Bessemer Group Inc. increased its holdings in GE HealthCare Technologies by 24.3% in the first quarter. Bessemer Group Inc. now owns 6,671 shares of the company's stock valued at $538,000 after purchasing an additional 1,306 shares during the last quarter. Finally, Wealth Enhancement Advisory Services LLC increased its holdings in GE HealthCare Technologies by 23.8% in the first quarter. Wealth Enhancement Advisory Services LLC now owns 50,859 shares of the company's stock valued at $4,105,000 after purchasing an additional 9,769 shares during the last quarter. Institutional investors and hedge funds own 82.06% of the company's stock.

GE HealthCare Technologies Trading Down 0.4%

Shares of GE HealthCare Technologies stock traded down $0.28 during trading hours on Friday, hitting $75.96. The company's stock had a trading volume of 3,302,966 shares, compared to its average volume of 3,554,740. The company has a debt-to-equity ratio of 0.73, a current ratio of 0.98 and a quick ratio of 0.76. The company has a market capitalization of $34.78 billion, a PE ratio of 15.99, a price-to-earnings-growth ratio of 2.54 and a beta of 1.14. The stock has a 50 day moving average of $72.85 and a 200 day moving average of $77.25. GE HealthCare Technologies Inc. has a 12 month low of $57.65 and a 12 month high of $94.80.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last posted its quarterly earnings data on Wednesday, April 30th. The company reported $1.01 earnings per share for the quarter, topping the consensus estimate of $0.91 by $0.10. The company had revenue of $4.78 billion during the quarter, compared to analysts' expectations of $4.66 billion. GE HealthCare Technologies had a return on equity of 24.95% and a net margin of 11.02%. GE HealthCare Technologies's revenue for the quarter was up 2.7% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.90 earnings per share. Analysts predict that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current year.

GE HealthCare Technologies Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, August 15th. Stockholders of record on Friday, July 25th will be given a dividend of $0.035 per share. The ex-dividend date is Friday, July 25th. This represents a $0.14 annualized dividend and a dividend yield of 0.18%. GE HealthCare Technologies's dividend payout ratio is currently 2.95%.

GE HealthCare Technologies declared that its board has authorized a stock repurchase program on Wednesday, April 30th that permits the company to buyback $1.00 billion in shares. This buyback authorization permits the company to repurchase up to 3.1% of its shares through open market purchases. Shares buyback programs are usually a sign that the company's board of directors believes its shares are undervalued.

Wall Street Analyst Weigh In

GEHC has been the subject of a number of recent analyst reports. BTIG Research reiterated a "buy" rating on shares of GE HealthCare Technologies in a report on Monday. Wells Fargo & Company dropped their price objective on GE HealthCare Technologies from $103.00 to $89.00 and set an "overweight" rating for the company in a report on Thursday, May 1st. Evercore ISI dropped their price objective on GE HealthCare Technologies from $96.00 to $85.00 and set an "outperform" rating for the company in a report on Thursday, May 1st. Piper Sandler lowered their price target on GE HealthCare Technologies from $104.00 to $88.00 and set an "overweight" rating for the company in a report on Wednesday, April 23rd. Finally, The Goldman Sachs Group lowered their price target on GE HealthCare Technologies from $94.00 to $82.00 and set a "buy" rating for the company in a report on Thursday, May 1st. Three research analysts have rated the stock with a hold rating, nine have issued a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $88.55.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.